Cargando…
Recent Advances in Treatment of Primary Central Nervous System Lymphoma
Therapeutic options are limited in primary central nervous system lymphoma (PCNSL) with no uniform consensus on optimal management and few published, randomized trials. High-dose methotrexate in combination with other chemotherapeutic agents forms the mainstay of treatment. There hasn’t been much pr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841579/ https://www.ncbi.nlm.nih.gov/pubmed/23934511 http://dx.doi.org/10.1007/s11864-013-0252-6 |